Nutraferon ONDON 4MG Tablet

Chemotherapy, radiation, and surgical anesthetics trigger gut cells to release a surge of serotonin (5-HT). Ondansetron acts as a selective molecular shield at 5-HT3 receptors on the vagus nerve and in the brain's chemoreceptor trigger zone, stopping the vomiting reflex.

Never self-medicate during pregnancy. Some epidemiological studies have investigated a small increased risk of congenital oral clefts (cleft palate) and cardiac septal defects with first-trimester Ondansetron exposure; therefore, in pregnancy (hyperemesis gravidarum), it is reserved strictly as a second-line option when prescribed by an obstetrician after first-line therapies (pyridoxine/doxylamine) fail.

Mild headache, transient constipation (as blocking gut 5-HT3 receptors slows colonic transit), and occasional flushing or warmth.

No. Because Ondansetron selectively targets serotonin 5-HT3 receptors rather than histamine or dopamine D2 receptors, it does not cause significant drowsiness or extrapyramidal muscle spasms.

Ondansetron causes dose-dependent QTc interval prolongation (risk of Torsades de Pointes—avoid in congenital long QT syndrome and correct hypokalemia/hypomagnesemia first). It is strictly contraindicated with Apomorphine (causes profound hypotension and loss of consciousness). Additionally, combining Ondansetron with SSRIs, SNRIs, MAOIs, fentanyl, tramadol, or linezolid carries a risk of Serotonin Syndrome (agitation, clonus, hyperthermia, tachycardia), and Ondansetron can partially reduce the analgesic effect of Tramadol (`80-Nutraferon TRADO TAB`).